This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 May 14;92(20):931-932.

doi: 10.1212/WNL.0000000000007494.

Status epilepticus: Will we capture the moment or continue without evidence of efficacy or costs?

Craig A Press¹, Kevin E Chapman²

Affiliations

Affiliations

¹ From Pediatric Neurocritical Care (C.A.P.) and Pediatric Epilepsy (K.E.C.), Departments of Pediatrics and Neurology (C.A.P., K.E.C.), University of Colorado at Denver.
² From Pediatric Neurocritical Care (C.A.P.) and Pediatric Epilepsy (K.E.C.), Departments of Pediatrics and Neurology (C.A.P., K.E.C.), University of Colorado at Denver. Kevin.Chapman@ucdenver.org.

PMID: 31068483
DOI: 10.1212/WNL.0000000000007494

Editorial

Status epilepticus: Will we capture the moment or continue without evidence of efficacy or costs?

Craig A Press et al. Neurology. 2019.

. 2019 May 14;92(20):931-932.

doi: 10.1212/WNL.0000000000007494.

Authors

Craig A Press¹, Kevin E Chapman²

Affiliations

¹ From Pediatric Neurocritical Care (C.A.P.) and Pediatric Epilepsy (K.E.C.), Departments of Pediatrics and Neurology (C.A.P., K.E.C.), University of Colorado at Denver.
² From Pediatric Neurocritical Care (C.A.P.) and Pediatric Epilepsy (K.E.C.), Departments of Pediatrics and Neurology (C.A.P., K.E.C.), University of Colorado at Denver. Kevin.Chapman@ucdenver.org.

PMID: 31068483
DOI: 10.1212/WNL.0000000000007494

No abstract available

PubMed Disclaimer

Comment on

Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
Sánchez Fernández I, Gaínza-Lein M, Lamb N, Loddenkemper T. Sánchez Fernández I, et al. Neurology. 2019 May 14;92(20):e2339-e2348. doi: 10.1212/WNL.0000000000007503. Neurology. 2019. PMID: 31068480

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.